Akari Therapeutics (AKTX) Form 3 Akari Therapeutics / Hoyoung Huh ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Huh Hoyoung

(Last) (First) (Middle)

C/O AKARI THERAPEUTICS, PLC

22 BOSTON WHARF ROAD FL 7

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/14/2024

3. Issuer Name and Ticker or Trading Symbol
Akari Therapeutics Plc [ AKTX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value $0.0001 per share(1)	7,605,994,000	D
Ordinary Shares, par value $0.0001 per share(1)	218,914,000	I	By Hannol Ventures LLC(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants (Right to Buy)	11/14/2024	04/28/2028	Ordinary Shares, par value $0.0001 per share(1)	103,482,000	0.001	D
Stock Option (Right to Buy)	(3)	09/24/2034	Ordinary Shares, par value $0.0001 per share(1)	704,400,000	0.0014	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.

2. Shares held by Hannol Ventures LLC, of which the Reporting Person is the sole member. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

3. Subject to the Reporting Person's continued service with the Issuer and there being an effective Form S-8 Registration Statement (a "Form S-8") on file with the SEC covering the issuance of the Ordinary Shares underlying such option, this option shall vest with respect to one third of the underlying shares on each of (i) the effective date of the Form S-8, (ii) December 31, 2024 and (iii) December 31, 2025.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Wendy F. DiCicco, as Attorney-in-Fact	11/22/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.